HomeTNYA • NASDAQ
add
Tenaya Therapeutics Inc
Previous close
$0.89
Day range
$0.82 - $0.90
Year range
$0.36 - $2.35
Market cap
185.57M USD
Avg Volume
5.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.78M | -15.73% |
Net income | -20.18M | 15.36% |
Net profit margin | — | — |
Earnings per share | -0.12 | 57.14% |
EBITDA | -18.95M | 16.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.55M | 63.63% |
Total assets | 146.92M | 22.50% |
Total liabilities | 23.66M | -12.66% |
Total equity | 123.26M | — |
Shares outstanding | 217.00M | — |
Price to book | 1.57 | — |
Return on assets | — | — |
Return on capital | -45.46% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -20.18M | 15.36% |
Cash from operations | — | — |
Cash from investing | -67.00K | -100.48% |
Cash from financing | 58.24M | 15,348.81% |
Net change in cash | 44.24M | 1,231.91% |
Free cash flow | -6.46M | 34.08% |
About
Founded
2016
Headquarters
Website
Employees
70
